Rockefeller Capital Management
HZNP

Rockefeller Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Rockefeller Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,755
Closed -$695K – 1878
2023
Q2 		$695K Sell
6,755
-2,280
-25% -$241K ﹤0.01% 1225
2023
Q1 		$985K Sell
9,035
-93,069
-91% -$10.3M ﹤0.01% 1089
2022
Q4 		$11.6M Buy
102,104
+99,791
+4,314% +$8.29M 0.06% 333
2022
Q3 		$143K Sell
2,313
-1,579
-41% -$110K ﹤0.01% 1808
2022
Q2 		$309K Buy
3,892
+1,789
+85% +$169K ﹤0.01% 1458
2022
Q1 		$220K Buy
2,103
+1,759
+511% +$171K ﹤0.01% 1642
2021
Q4 		$36K Buy
344
+63
+22% +$6.87K ﹤0.01% 2362
2021
Q3 		$29K Sell
281
-609
-68% -$63.2K ﹤0.01% 2422
2021
Q2 		$82K Sell
890
-116
-12% -$10.7K ﹤0.01% 1883
2021
Q1 		$92K Sell
1,006
-1,521
-60% -$128K ﹤0.01% 1645
2020
Q4 		$184K Hold
2,527
– – ﹤0.01% 1224
2020
Q3 		$195K Buy
2,527
+1,780
+238% +$122K ﹤0.01% 1050
2020
Q2 		$42K Sell
747
-152
-17% -$6.5K ﹤0.01% 1455
2020
Q1 		$27K Hold
899
– – ﹤0.01% 1417
2019
Q4 		$33K Buy
899
+53
+6% +$1.63K ﹤0.01% 1261
2019
Q3 		$23K Sell
846
-57
-6% -$1.47K ﹤0.01% 1188
2019
Q2 		$22K Sell
903
-529
-37% -$13.4K ﹤0.01% 1007
2019
Q1 		$38K Buy
+1,432
New +$33.9K ﹤0.01% 1004

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rockefeller Capital Management's HZNP Position: Q3 2023 in Review

Rockefeller Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 6,755 shares — an estimated $695K sold.

Rockefeller Capital Management first reported a position in HZNP in Q1 2019 and held it in 18 quarters. The position peaked at $11.6M in Q4 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Rockefeller Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 6,755 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $695K.
  • Rockefeller Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 18 quarters.
  • Rockefeller Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $11.6M in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Rockefeller Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.